Oxurion NV (EBR:OXUR)
Belgium · Delayed Price · Currency is EUR 0.0040
+0.0004 (11.11%)
May 22, 2026, 5:27 PM CET
Oxurion NV Market Cap
Oxurion NV has a market cap or net worth of €354.77 thousand as of May 22, 2026. Its market cap has decreased by -17.67% in one year.
Market Cap
354.77K
Enterprise Value
11.57M
Revenue
555.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since July 7, 2006, Oxurion NV's market cap has decreased from 100.46M to 354.77K, a decrease of -99.65%. That is a compound annual growth rate of -24.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 319.29K | -29.16% |
| Dec 31, 2025 | 450.71K | -41.17% |
| Dec 31, 2024 | 766.13K | -73.79% |
| Dec 29, 2023 | 2.92M | -62.57% |
| Dec 30, 2022 | 7.81M | -88.99% |
| Dec 31, 2021 | 70.93M | -27.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 45.86B |
| argenx SE | 43.92B |
| Financière de Tubize | 9.25B |
| Onward Medical | 195.03M |
| Hyloris Pharmaceuticals | 141.12M |
| European Medical Solutions | 22.85M |
| Celyad Oncology | 13.43M |
| BioSenic | 1.44M |